TY - JOUR UR - https://doi.org/10.25259/IJMIO-3-2019 DO - 10.25259/IJMIO-3-2019 TI - Special considerations for consent in immuno-oncology - Medic LAWgic recommendations AU - Parikh,Purvish M. AU - Jhaveri,Karishma AU - Bahl,Ankur AU - Talwar,Vineet AU - Gandhi,Pritish AU - Singh,Randeep AU - Shreshta,Sudeep AU - Sahoo,TP AB - Novel immuno-oncology medications are a new addition to the armamentarium in the fight against cancer. This new class of drugs have unique toxicities whose understanding is constantly evolving. Today more is published in scientific literature every year then we can test in our lifetime. Hence we need to take advantage of existing technology to improve the experience of the healthcare team as well as the patients and care givers while going through available literature and information. This will improve understanding and empower the patients to participate actively in the decision making process. This manuscript is an initiative to achieve this objective. VL - 4 T2 - International Journal of Molecular and Immuno Oncology JO - International Journal of Molecular and Immuno Oncology J2 - International Journal of Molecular and Immuno Oncology SN - 2456-3994 ER -